Phreesia PHR 深 滬
等待開盤 04-01 09:30:00 美东时间
8.38
-3.030
-26.56%
華盛通- 最 高9.00
- 今 開8.02
- 成交量 1631.91万股
- 最 低 7.77
- 昨 收 11.41
- 總市值 5.05亿
- 52周最高 32.76
- 市盈率 靜 223.47
- 換手率 27.07%
- 52周最低 7.77
- 委 比 -88.24%
- 總股本 6028.70万
- 歷史最高 81.592
- 量 比 9.81
- 振 幅 10.78%
- 歷史最低 7.77
- 每 手 1
- 風險率 5.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Citigroup Downgrades Phreesia to Neutral, Lowers Price Target to $10
Citigroup analyst Daniel Grosslight downgrades Phreesia (NYSE:PHR) from Buy to Neutral and lowers the price target from $25 to $10.
今天 02:39
Why Is Phreesia Stock Sinking Tuesday?
Phreesia (PHR) stock plunges 26% in premarket after lowering its FY2027 revenue outlook due to softening pharma spending. Get the details.
03-31 20:15
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Apellis Pharmaceuticals (NASDAQ:APLS) shares moved upwards by 138.8% t...
03-31 20:05
BUZZ-U.S. STOCKS ON THE MOVE-McCormick, Centessa, Apellis
BUZZ-U.S. STOCKS ON THE MOVE-McCormick, Centessa, Apellis Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 31 (Reuters) - U.S. stock index futures gained on Tuesday, as mark
03-31 19:43
BUZZ-Phreesia stock tumbles on lowered 2027 revenue outlook
BUZZ-Phreesia stock tumbles on lowered 2027 revenue outlook ** Shares of digital healthcare services platform Phreesia PHR.N slump 26.64% to $8.37 premarket ** Co lowered fiscal 2027 revenue outlook due to reduced pharma client spending commitments ** Co lowers FY 2027 revenue outlook to $510 mln-$5
03-31 16:47
U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks
U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks March 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dutch Bros, Phreesia and Starbucks on Tuesday. HIGHLIGHTS * Dutch Bros Inc BROS.N : Exane BNP Paribas initiat
03-31 15:39
Phreesia Lowers FY2027 Sales Guidance from $545.000M-$559.000M to $510.000M-$520.000M
Phreesia (NYSE:PHR) lowers FY2027 sales outlook from $545.000 million-$559.000 million to $510.000 million-$520.000 million.
03-31 04:05
Phreesia Q4 EPS $0.02 Misses $0.07 Estimate, Sales $127.067M Beat $126.617M Estimate
Phreesia (NYSE:PHR) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.07 by 70.59 percent. This is a 118.18 percent increase over losses of $(0.11) per share from the same
03-31 04:04
